Preview

Современная ревматология

Расширенный поиск

Качество жизни больных подагрой

https://doi.org/10.14412/1996-7012-2011-695

Полный текст:

Литература

1. <div><p>Насонова В.А., Барскова В.Г. Ранние диагностика и лечение подагры - научно обоснованное требование улучшения трудового и жизненного прогноза больных. Науч-практич ревматол 2004;1:5-7</p><p>Lawrence R.C., Helmick C.G., Arnett F.C. et al. Estimates of the prevalence of arthritis and selected musculoskeletal diseases in the United States. Arthr Rheum 1998;41:778-99.</p><p>Saag K.G., Choi H. Epidemiology, risk factors, and lifestyle modifications for gout. ОБЗОР Arthr Res Ther 2006;8(Suppl. 1):2.</p><p>Roddy E., Zhang W., Doherty M. The changing epidemiology of gout. Nat Clin Pract Rheum 2007;3:443-9.</p><p>Luk A.J., Simkin P.A. Epidemiology of hyperuricemia and gout. Am J Manag Care 2005;11(15 Suppl.):S435-S442</p><p>Choi H.K., Curhan G. Soft drinks, fructose consumption, and the risk of gout in men - A prospective cohort study. BMJ 2008;336(7639):309-12.</p><p>Kim K.Y., Schumacher H.R., Hunsche E. et al. A literature review of the epidemiology and treatment of acute gout. Clin Ther 2003;25:1593-617.</p><p>Mikuls T.R., Farrar J.T., Bilker W.B. et al. The treatment of asymptomatic hyper-uricemia: results from the population-based general practice research database (GPRD). Arthr Rheum 2003;48(Suppl. 9):S612.</p><p>Mikuls T.R., Farrar J.T., Bilker W.B. et al. Gout epidemiology: results from the UK General Practice Research Database, 1990-1999. Ann Rheum Dis 2005;64:267-72.</p><p>Ланг Г.Ф. Гипертоническая болезнь. М.: Медгиз, 1950;495</p><p>Kylin E. Studien ueber das Hypertonie-Hyperglyka «mie-Hyperurika» miesyndrom. Zentralblatt Innere Med 1923;44:105-27.</p><p>Annemans L., Spaepen E., Gaskin M. et al. Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000-2005. Ann Rheum Dis 2008;67:960-6.</p><p>Edwards N.L. The role of hyper-uricemia and gout in kidney and cardiovascular disease. Cleve Clin J Med 2008;75(Suppl. 5):S13-S16.</p><p>Van den Bussche H., Koller D., Kolonko T. et al. Which chronic diseases and disease combinations are specific to multimorbidity in the elderly? Results of a claims data based cross-sectional study in Germany. BMC Public Health 2011;11(1):101</p><p>Reidel A.A., Nelson M., Joseph-Ridge N. et al. Compliance with allopurinol therapy among managed care enrolees with gout: a retrospective analysis of administrative claims. J Rheumatol 2004;31:1575-81.</p><p>Елисеев М.С., Барскова В.Г. Нарушения углеводного обмена при подагре: частота выявления и клинические особенности. Тер арх 2010;5:50-4.</p><p>Новик А.А., Ионова Т.И. Руководство по исследованию качества жизни в медицине. СПб.: Олма-Пресс, 2002;300</p><p>Амирджанова В.Н. Качество жизни больных ревматоидным артритом, получающих ритуксимаб. Науч-практич ревматол 2008 (прил. к №1):15-20.</p><p>Pouchot J. Toward individualized quality of life assessment. J Bone Spin 2000;67(2):83-5.</p><p>Taylor W.J., Schumacher H.R. Jr., Baraf H.S.B. et al. A modified Delphi exercise to determine the extent of consensus with OMERACT outcome domains for studies of acute and chronic gout. Ann Rheum Dis 2008;67:888-91.</p><p>Susan J.L., Hirsch J.D., Terkeltaub R. Perceptions of disease and health-related quality of life among patients with gout. Rheumatology 2009;48:582-6.</p><p>Roddy E., Zhang W., Doherty M. Concordance of the management of chronic gout in a UK primary-care popylation with the EULAR gout recommendations. Ann Rheum Dis 2007;66:1311-5.</p><p>Kawata A.K., Benjamin K.L., Waltrip R.W. et al. Validation of the SF-36 and HAQ-DI in patients with treatment-failure gout. Ann Rheum Dis 2007;66(Suppl. II):236.</p><p>Singh J.A., Strand V. Gout is associated with more comorbidities, poorer health-related quality of life and higher healthcare utilisation in US veterans. Ann Rheum Dis 2008;67:1310-6.</p><p>Strand V., Singh J.A., Sundy J. et al. Health related quality of life of patients with refractory gout and US Veterans Administration patients with gout and comorbidities is poor and comparable to that in other severe chronic conditions. Arthr Rheum 2008;58(Suppl.):177.</p><p>Singh J.A., Yang S., Strand V. et al. Validation of pain and patient global scales in chronic gout: data from two randomized controlled trials. Ann Rheum Dis 2011;70:1277-81.</p><p>Strand V., Edwards L., Singh J. Health-related quality of life (HRQOL) of patients with treatment failure gout is poor, and comparable to that in other severe chronic conditions Ann Rheum Dis 2009;68(Suppl. 3):168</p><p>Gupta N., Bedi G.S., Khanna S. et al. Health related quality of life of patients with rheumatoid arthrities and systemic lupus erythematosus in India- a comparison. Qual Life Res 2005;14(8):1953-8.</p></div><br />


Для цитирования:


Eliseyev M.S., Мукагова М.В., Барскова В.Г. Качество жизни больных подагрой. Современная ревматология. 2011;5(4):35-38. https://doi.org/10.14412/1996-7012-2011-695

For citation:


Eliseyev M.S., Mukagova M.V., Barskova V.G. Kachestvo zhizni bol'nykh podagroy. Modern Rheumatology Journal. 2011;5(4):35-38. (In Russ.) https://doi.org/10.14412/1996-7012-2011-695

Просмотров: 637


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 1996-7012 (Print)
ISSN 2310-158X (Online)